S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NYSE:CBZ

CBIZ (CBZ) Stock Price, News & Analysis

$74.92
+0.70 (+0.94%)
(As of 04:37 PM ET)
Today's Range
$74.12
$75.09
50-Day Range
$63.35
$78.50
52-Week Range
$49.13
$79.55
Volume
187,823 shs
Average Volume
306,963 shs
Market Capitalization
$3.75 billion
P/E Ratio
31.48
Dividend Yield
N/A
Price Target
$63.00

CBIZ MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
15.9% Downside
$63.00 Price Target
Short Interest
Bearish
2.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.61
Upright™ Environmental Score
News Sentiment
0.05mentions of CBIZ in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.04%
From $2.74 to $3.07 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.21 out of 5 stars

Business Services Sector

198th out of 305 stocks

Business Services, Not Elsewhere Classified Industry

66th out of 89 stocks

CBZ stock logo

About CBIZ Stock (NYSE:CBZ)

CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services. The Benefits and Insurance Services provides employee benefits consulting, payroll/human capital management, property and casualty insurance, and retirement and investment services. The National Practices segment offers information technology managed networking and hardware, and health care consulting services. The company primarily serves small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises. CBIZ, Inc. was incorporated in 1987 and is headquartered in Independence, Ohio.

CBZ Stock Price History

CBZ Stock News Headlines

CBIZ (NYSE:CBZ) versus Fiserv (NYSE:FI) Critical Contrast
CBIZ (CBZ) Scheduled to Post Quarterly Earnings on Thursday
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
CBIZ, Inc. (CBZ)
15 States with No or Low Income Tax Rates
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Returns At CBIZ (NYSE:CBZ) Appear To Be Weighed Down
CBZ Apr 2024 60.000 put
CBIZ ACQUIRES COMPUDATA, INC.
16 States With the Lowest Or No Sales Tax
CBIZ Full Year 2023 Earnings: Beats Expectations
CBZ Mar 2024 90.000 call
See More Headlines
Receive CBZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CBIZ and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/19/2024
Next Earnings (Confirmed)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Research & Consulting Services
CUSIP
12480510
Employees
6,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$63.00
High Stock Price Target
$63.00
Low Stock Price Target
$63.00
Potential Upside/Downside
-15.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$120.97 million
Pretax Margin
10.45%

Debt

Sales & Book Value

Annual Sales
$1.59 billion
Cash Flow
$3.20 per share
Book Value
$15.88 per share

Miscellaneous

Free Float
47,406,000
Market Cap
$3.72 billion
Optionable
Optionable
Beta
0.83
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

CBZ Stock Analysis - Frequently Asked Questions

Should I buy or sell CBIZ stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CBIZ in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CBZ shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CBZ, but not buy additional shares or sell existing shares.
View CBZ analyst ratings
or view top-rated stocks.

What is CBIZ's stock price target for 2024?

1 Wall Street research analysts have issued 1-year price objectives for CBIZ's stock. Their CBZ share price targets range from $63.00 to $63.00. On average, they predict the company's stock price to reach $63.00 in the next year. This suggests that the stock has a possible downside of 15.9%.
View analysts price targets for CBZ
or view top-rated stocks among Wall Street analysts.

How have CBZ shares performed in 2024?

CBIZ's stock was trading at $62.59 at the start of the year. Since then, CBZ stock has increased by 19.7% and is now trading at $74.92.
View the best growth stocks for 2024 here
.

Are investors shorting CBIZ?

CBIZ saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 1,270,000 shares, an increase of 61.2% from the March 15th total of 788,000 shares. Based on an average trading volume of 313,100 shares, the days-to-cover ratio is currently 4.1 days. Approximately 2.7% of the shares of the company are short sold.
View CBIZ's Short Interest
.

When is CBIZ's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our CBZ earnings forecast
.

How can I listen to CBIZ's earnings call?

CBIZ will be holding an earnings conference call on Thursday, April 25th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were CBIZ's earnings last quarter?

CBIZ, Inc. (NYSE:CBZ) announced its quarterly earnings results on Thursday, February, 15th. The business services provider reported ($0.26) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.01. The business services provider had revenue of $327.50 million for the quarter, compared to the consensus estimate of $308.87 million. CBIZ had a net margin of 7.60% and a trailing twelve-month return on equity of 15.49%. CBIZ's revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.21) earnings per share.

What guidance has CBIZ issued on next quarter's earnings?

CBIZ updated its FY 2024 earnings guidance on Friday, February, 16th. The company provided earnings per share (EPS) guidance of 2.700-2.750 for the period, compared to the consensus EPS estimate of 2.670. The company issued revenue guidance of $1.7 billion-$1.7 billion, compared to the consensus revenue estimate of $1.7 billion.

What is Jerry Grisko's approval rating as CBIZ's CEO?

57 employees have rated CBIZ Chief Executive Officer Jerry Grisko on Glassdoor.com. Jerry Grisko has an approval rating of 84% among the company's employees.

What other stocks do shareholders of CBIZ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CBIZ investors own include Walt Disney (DIS), Veracyte (VCYT), Carnival Co. & (CCL), CRISPR Therapeutics (CRSP), Etsy (ETSY), Gilead Sciences (GILD), Johnson & Johnson (JNJ), KeyCorp (KEY), Altria Group (MO) and NeoGenomics (NEO).

Who are CBIZ's major shareholders?

CBIZ's stock is owned by many different institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (2.35%), Artemis Investment Management LLP (0.44%), Chatham Capital Group Inc. (0.10%), Bridge City Capital LLC (0.09%), CWM LLC (0.04%) and Valeo Financial Advisors LLC (0.03%). Insiders that own company stock include Benaree Pratt Wiley, Chris Spurio, Jerome P Grisko, Joseph S Dimartino, Michael P Kouzelos, Rajesh Vashist, Sherrill W Hudson, Steven L Gerard, Todd J Slotkin and Ware H Grove.
View institutional ownership trends
.

How do I buy shares of CBIZ?

Shares of CBZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CBZ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners